Clinical evaluation of zavegepant for the acute treatment of migraine

被引：0

作者：

Fan, Huiqiao ^{[1
]}

Wadolowski, Janette ^{[1
]}

Shan, Ryan ^{[1
]}

Contrera, Gianni J. ^{[1
]}

Polomoff, Christina M. ^{[1
]}

机构：

[1] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA

来源：

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2025年 / 31卷 / 06期

关键词：

BURDEN; PHARMACOKINETICS; PATHOPHYSIOLOGY; PREVALENCE;

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Zavegepant is the first intranasal calcitonin gene-related peptide receptor antagonist approved for the acute treatment of migraine and offers a new nonoral option for patients. This article reports the findings of a comprehensive literature review to assess zavegepant's safety and effectiveness. Evidence synthesis involved reporting findings from clinical trials and evaluating comparative effectiveness. This review was prepared by the University of Connecticut School of Pharmacy Academy of Managed Care Pharmacy (AMCP) Student Chapter. The student author group won the AMCP National Pharmacy and Therapeutics competition for their zavegepant product review in March 2024.

引用

页码：598 / 602

页数：5

共 43 条

[1] The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice [J].

Ailani, Jessica ;

Burch, Rebecca C. ;

Robbins, Matthew S. .

HEADACHE, 2021, 61 (07) :1021-1039

[2]

[Anonymous], NURTEC ODCT (rimegepant) orally disintegrating tablets. Prescribing information

[3]

[Anonymous], EudraVigilance-European database of suspected adverse drug reaction reports (ADR Reports)

[4]

[Anonymous], 2013, Center for Medicare Medicaid Services certification and survey provider enhanced reporting (CMS-CASPER) formerly OSCAR data as of June 2013

[5]

[Anonymous], ZAVZPRET (zavegepant) nasal spray. Prescribing information

[6] Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial [J].

Berman, Gary ;

Mullin, Kathleen ;

Pavlovic, Jelena ;

Smith, Timothy ;

Croop, Robert ;

Madonia, Jennifer ;

Mosher, Linda ;

Hould, Jennifer ;

Lipton, Richard .

NEUROLOGY, 2023, 100 (17)

[7]

Bertz R, 2022, HEADACHE, V62, P108

[8] Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment [J].

Bhardwaj, Rajinder ;

Donohue, Mary K. ;

Madonia, Jennifer ;

Morris, Beth ;

Marbury, Thomas C. ;

Matschke, Kyle T. ;

Croop, Robert ;

Bertz, Richard ;

Liu, Jing .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (07)

[9]

Bhardwaj R, 2022, CEPHALALGIA, V42, P79

[10] Exploring the Hereditary Nature of Migraine [J].

Bron, Charlene ;

Sutherland, Heidi G. ;

Griffiths, Lyn R. .

NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 :1183-1194

← 1 2 3 4 5 →